US equities
|
SPCX
$175.03
▲+2.30%
NVDA
$241.75
▲+1.19%
MU
$1,060.57
▼-0.32%
MRVL
$290.79
▲+7.20%
AMD
$646.15
▲+2.28%
SNDK
$1,662.81
▼-2.43%
TSLA
$380.57
▲+0.49%
AVGO
$374.77
▲+3.38%
SPCX
$175.03
▲+2.30%
NVDA
$241.75
▲+1.19%
MU
$1,060.57
▼-0.32%
MRVL
$290.79
▲+7.20%
AMD
$646.15
▲+2.28%
SNDK
$1,662.81
▼-2.43%
TSLA
$380.57
▲+0.49%
AVGO
$374.77
▲+3.38%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about XNYS:NNVC
Recent news which mentions XNYS:NNVC
NanoViricides updates progress on Phase 1a/1b clinical trial of antiviral drug candidate NV-387
November 29, 2023
Tags
NanoViricides
XNYS:NNVC
From
TheNewswire.com - RSS (Media)
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
September 27, 2023
Tickers
AZN
GSK
PFE
SNY
Tags
NanoViricides, Inc/
XNYS:NNVC
From
TheNewswire.com - RSS (Media)
NanoViricides progressing well with new Covid study
August 31, 2023
Tags
XNYS:NNVC
NanoViricides
From
TheNewswire.com - RSS (Media)
SARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?
July 19, 2023
Tickers
GILD
MRK
PFE
Tags
NanoViricides, Inc/
XNYS:NNVC
From
TheNewswire.com - RSS (Media)
NanoViricides testing oral gummy and syrup Covid-19 treatment - Proactive Research Analyst
July 13, 2023
Tags
NanoViricides
XNYS:NNVC
From
TheNewswire.com - RSS (Media)
Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target?
July 11, 2023
Tickers
GILD
MRK
PFE
Tags
XNYS:NNVC
NanoViricides, Inc/
From
TheNewswire.com - RSS (Media)
NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment
July 06, 2023
Tickers
GILD
MRK
PFE
Tags
XNYS:NNVC
NanoViricides, Inc/
From
TheNewswire.com - RSS (Media)
NanoViricides take big step forward beginning trials on its antiviral drug NV-CoV-2
June 29, 2023
Tags
NanoViricides
XNYS:NNVC
From
TheNewswire.com - RSS (Media)
NanoViricides using unique technology platform to fight against viruses
April 12, 2023
Tags
NanoViricides
XNYS:NNVC
From
TheNewswire.com - RSS (Media)
COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All
March 31, 2023
Tickers
AZN
GILD
MRK
MRNA
Tags
XNYS:NNVC
NanoViricides, Inc/
From
TheNewswire.com - RSS (Media)
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
March 20, 2023
Tickers
GILD
MRK
MRNA
NVAX
Tags
NanoViricides, Inc/
XNYS:NNVC
From
TheNewswire.com - RSS (Media)
With Nearly 20,000 Americans Still Hospitalized, COVID Remains A Threat – NanoViricides Gets Ready To Begin Clinical Trials For The World To Defeat It
March 08, 2023
Tickers
NNVC
Tags
NanoViricides, Inc/
XNYS:NNVC
From
TheNewswire.com - RSS (Media)
This Company Is Looking For A Monkeypox Drug As City Investigates Deaths
October 27, 2022
Tickers
NNVC
Tags
NanoViricides, Inc/
XNYS:NNVC
From
TheNewswire.com - RSS (Media)
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
September 19, 2022
Tickers
CTLT
GILD
SIGA
Tags
NanoViricides, Inc/
XNYS:NNVC
From
TheNewswire.com - RSS (Media)
Monkeypox Is Popping Up In Places It Shouldn’t But NanoViricides Says It May Have A Solution
August 10, 2022
Tickers
SIGA
Tags
XNYS:NNVC
NanoViricides, Inc/
From
TheNewswire.com - RSS (Media)